Developer docs
API playgroundTry for free, no card

Search company profiles

Visfo

Full company profile

uuid000jbxk

Namestring
Visfo
Legal namestring
VISFO
Websiteurl
visfo.health
Company typeenum
Private
Founded yearint
2018
Descriptiontext

Visfo is a UK-based healthtech consultancy and software provider that serves pharmaceutical, biotechnology, and consumer health companies with strategic intelligence, data science, and software solutions. The firm was founded by Dr. Max Noble (CEO) and operates from West Yorkshire, England, with clients worldwide across the US and European markets. Its positioning is built on combining cross-functional consulting expertise — spanning market access, R&D, medical affairs, evidence development, and commercial strategy — with a proprietary software platform, addressing the market need for healthcare teams to act on fragmented clinical, scientific, competitive, and digital data.

The company's core product is HelixAI, a collaborative delivery system that structures projects from scoping through solution with built-in communication, self-serve analytics, AI-powered summarization of dense scientific publications, custom alerts, and integrated insight feeds. HelixAI is fed by four data landscapes — Clinical (claims data, EHRs, trial site metrics), Scientific (literature mapping, author disambiguation, topic modeling), Competitive (trial design, pipelines, pricing, HTA decisions) and Digital (social media, forums, DOL tracking, sentiment analysis) — combined with NLP, machine learning, and statistical modeling. These data modules power bespoke Intelligence Boards and dashboards developed during consulting engagements and matured into enterprise software.

Visfo makes money through a hybrid model: short-duration, high-impact data-science consulting engagements (professional services) that typically convert into multi-year, customized SaaS subscriptions on HelixAI and bespoke enterprise software. Pricing is quote-based and not publicly disclosed. The company sells exclusively through direct enterprise field sales — no resellers, marketplaces, or self-service distribution — and its solution initiation flow is supported by a Solutions Builder tool on its website. Named clients include Pfizer, AbbVie, Bayer, Gilead, Janssen, Takeda, Allergan, Sumitomo, and Reckitt, with documented partnerships including the University of York and Oncology Access Solutions.

Short descriptiontext

Visfo is a UK-based healthtech consultancy and software provider that combines data science consulting with its proprietary HelixAI platform to deliver strategic intelligence, evidence development, and bespoke enterprise software to pharmaceutical, biotech, and consumer health companies worldwide.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBrighouse, United Kingdom
HQ citystring
Brighouse
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical intelligence consulting, healthcare data analytics, clinical trial optimization, competitive intelligence platforms, life sciences consulting
Industry3 codes
PRIMARYBPAEAHAD
Business Intelligence, Reporting & Visualization Services
SECONDARYHLAGALAJ
PV Regulatory Submissions & Safety Reporting (E2B/CIOMS/Expedited)
SECONDARYBPAHACAA
Strategy & Corporate Development Consulting
NAICS code5 codes
  • Management Consulting Services54161
  • Other Management Consulting Services541618
  • Computer Systems Design and Related Services5415
  • Computer Systems Design and Related Services54151
  • Marketing Consulting Services541613
SIC code3 codes
  • Services-Management Consulting Services8742
  • Services-Computer Programming Services7371
  • Services-Prepackaged Software7372
Product category
Pharmaceutical Intelligence Software
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Strategic Consulting Services
TypeProfessional Services
Description

High-impact data science consulting engagements that solve immediate client challenges. Projects typically deliver working data science solutions in weeks, combining internal client data with Visfo's external data landscape and domain expertise across market access, R&D, medical affairs, and more.

visfo.health
2SaaS Software Platform (HelixAI)
TypeSubscription Recurring
Description

Software solutions delivered through their HelixAI platform, providing ongoing access to intelligence tools, dashboards, and AI-powered features. Solutions scale from rapid prototypes to full enterprise software tailored to client business needs.

visfo.health
3Software Development and Customization
TypeSubscription Recurring
Description

Custom software development services that transform consulting solutions into scalable enterprise platforms. Development and deployment of enterprise-ready software tailored to client business, eliminating repeat work and embedding long-term strategic advantage.

visfo.health
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Operations, Marketing or Sales
Pricing details1 tier
1Custom enterprise engagement - pricing based on project scope and complexity
ModelOtherBilling cadenceMulti-year contract
Notes

Pricing is determined through direct consultation based on project requirements, data scope, and solution complexity. No public pricing tiers or standard rates disclosed.

visfo.health
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

Visfo is a UK-based life sciences strategic intelligence company that combines consulting engagements with a proprietary SaaS platform to help pharmaceutical, biotech, and consumer health organizations solve complex data challenges. The company delivers high-impact data science consulting projects spanning market access, R&D, medical affairs, and commercial decision support, alongside its HelixAI delivery platform that structures projects from scoping to solution with AI-powered summarization, self-serve analytics, and integrated insight feeds. Engagements typically begin as consulting projects and evolve into longer-term enterprise software relationships built on a comprehensive healthcare data landscape covering clinical, scientific, competitive, and digital domains.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Initial delivery in 4 weeks for FDA approval analysis case
+2 more records
Product overview1 text field

VISFO is a life sciences strategic intelligence company that combines SaaS consulting services with a proprietary software platform. Its core product is HelixAI, an AI-enhanced delivery system that structures data science projects from scoping through solution, providing self-serve analytics, AI-powered publication summarization, custom alerts, and integrated insight feeds. Complementing HelixAI are four data landscape modules — Clinical, Scientific, Competitive, and Digital — covering claims data, literature mapping, competitive pipelines, and social/digital signals. These data modules feed into tailored interactive Intelligence Boards and Dashboards developed during consulting engagements. The company pairs consulting engagements with rapid software prototyping, maturing validated solutions into enterprise-grade custom software.

Product and service1 record
1HelixAI
Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-01-01
Description

Partnership includes the Enigma scholarship programme for undergraduate students from widening participation backgrounds. The collaboration also involves research partnerships with PhD students working within Haematology Malignancy Diagnostic Services at St James's University Hospital. Visfo's founder established the scholarship programme to widen participation in the healthcare technology sector.

2Oncology Access Solutions
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-01-01
Description

Collaboration to author a publication on critical success factors for developing CAR T-cell therapies for cancer. The partnership focuses on planning the road ahead for CAR-T development and creating a modified approach to developing Target Product Profiles (TPP). Both companies contribute expertise in oncology market access and strategic intelligence.

visfo.health
Strategic tierSecondaryTypeOthers
Description

Takeda appears as a client logo on Visfo's website, indicating an active client relationship in the pharmaceutical sector.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Data analytics and AI platform company serving pharma with commercial operations, real-world evidence, and customer engagement solutions - directly comparable to VISFO's data science + software stack for life sciences.

TypeBroad incumbent
Description

Provides pharma market intelligence, clinical trial data, and industry analytics across multiple therapeutic areas. Comparable to VISFO's competitive and scientific landscape offerings.

TypeDirect peer
Description

US-based strategic consulting and analytics firm serving pharma and biotech with commercial strategy, competitive intelligence, and evidence generation - very similar offering to VISFO's consulting-plus-platform model.

TypeDirect peer
Description

Specialist pharma strategic analytics firm using AI and data science to support commercial strategy, market access, and launch decisions across pharma clients - very close fit to VISFO's consulting model.

TypeDirect peer
Description

Provides commercial intelligence and forecasting for pharma, including pipeline, pricing, and market access data. Comparable to VISFO's competitive landscape and market access offerings.

TypeDirect peer
Description

Healthcare strategy consulting firm supporting pharma, biotech, and medtech with commercial strategy, market access, and opportunity assessments. Comparable consulting services to VISFO's strategic intelligence practice.

TypeBroad incumbent
Description

Provides pharma intelligence, clinical trial data, and drug development analytics. Their analytics products and competitive intelligence databases directly compete with VISFO's clinical and competitive data landscape modules.

TypeBroad incumbent
Description

Global leader in life sciences analytics, R&D services, and commercial intelligence. Overlaps with VISFO's pharma intelligence, market access, and consulting offerings, but as part of a much broader portfolio.

TypeDirect peer
Description

Provider of healthcare commercial intelligence, analytics, and SaaS to life sciences companies. Overlaps with VISFO's clinical/competitive intelligence and data landscape products.

10ZS Associates
TypeDirect peer
Description

Global consulting and technology firm helping pharma companies with sales, marketing, and analytics strategies. Their AI/data capabilities and pharma focus mirror VISFO's strategic intelligence and SaaS delivery model.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers12 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability8 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Visfo

Pharmaceutical Intelligence Softwarevisfo.health

Visfo is a UK-based healthtech consultancy and software provider that combines data science consulting with its proprietary HelixAI platform to deliver strategic intelligence, evidence development, and bespoke enterprise software to pharmaceutical, biotech, and consumer health companies worldwide.

What Visfo does

Visfo is a UK-based healthtech consultancy and software provider that serves pharmaceutical, biotechnology, and consumer health companies with strategic intelligence, data science, and software solutions. The firm was founded by Dr. Max Noble (CEO) and operates from West Yorkshire, England, with clients worldwide across the US and European markets. Its positioning is built on combining cross-functional consulting expertise — spanning market access, R&D, medical affairs, evidence development, and commercial strategy — with a proprietary software platform, addressing the market need for healthcare teams to act on fragmented clinical, scientific, competitive, and digital data.

The company's core product is HelixAI, a collaborative delivery system that structures projects from scoping through solution with built-in communication, self-serve analytics, AI-powered summarization of dense scientific publications, custom alerts, and integrated insight feeds. HelixAI is fed by four data landscapes — Clinical (claims data, EHRs, trial site metrics), Scientific (literature mapping, author disambiguation, topic modeling), Competitive (trial design, pipelines, pricing, HTA decisions) and Digital (social media, forums, DOL tracking, sentiment analysis) — combined with NLP, machine learning, and statistical modeling. These data modules power bespoke Intelligence Boards and dashboards developed during consulting engagements and matured into enterprise software.

Visfo makes money through a hybrid model: short-duration, high-impact data-science consulting engagements (professional services) that typically convert into multi-year, customized SaaS subscriptions on HelixAI and bespoke enterprise software. Pricing is quote-based and not publicly disclosed. The company sells exclusively through direct enterprise field sales — no resellers, marketplaces, or self-service distribution — and its solution initiation flow is supported by a Solutions Builder tool on its website. Named clients include Pfizer, AbbVie, Bayer, Gilead, Janssen, Takeda, Allergan, Sumitomo, and Reckitt, with documented partnerships including the University of York and Oncology Access Solutions.

Visfo firmographics

Firmographics
Name
Visfo
Legal name
VISFO
Website
https://visfo.health
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
11–50 employees
Short description
Visfo is a UK-based healthtech consultancy and software provider that combines data science consulting with its proprietary HelixAI platform to deliver strategic intelligence, evidence development, and bespoke enterprise software to pharmaceutical, biotech, and consumer health companies worldwide.
Ownership category
akta.pro rank

Visfo industry classification

Industry
Product category
Pharmaceutical Intelligence Software
NAICS
Management Consulting Services (54161), Other Management Consulting Services (541618), Computer Systems Design and Related Services (5415), Computer Systems Design and Related Services (54151), Marketing Consulting Services (541613)
SIC
Services-Management Consulting Services (8742), Services-Computer Programming Services (7371), Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYBPAEAHAD
Business Intelligence, Reporting & Visualization Services
SECONDARYHLAGALAJ
PV Regulatory Submissions & Safety Reporting (E2B/CIOMS/Expedited)
SECONDARYBPAHACAA
Strategy & Corporate Development Consulting

Keywords

  • Pharmaceutical intelligence consulting
  • Healthcare data analytics
  • Clinical trial optimization
  • Competitive intelligence platforms
  • Life sciences consulting

Where Visfo is headquartered

Location

Headquarters

HQ city
Brighouse
HQ country
United Kingdom
HQ region
Europe

Offices2 records

Markets served

Visfo business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

  1. Strategic Consulting Services: High-impact data science consulting engagements that solve immediate client challenges. Projects typically deliver working data science solutions in weeks, combining internal client data with Visfo's external data landscape and domain expertise across market access, R&D, medical affairs, and more.
  2. SaaS Software Platform (HelixAI): Software solutions delivered through their HelixAI platform, providing ongoing access to intelligence tools, dashboards, and AI-powered features. Solutions scale from rapid prototypes to full enterprise software tailored to client business needs.
  3. Software Development and Customization: Custom software development services that transform consulting solutions into scalable enterprise platforms. Development and deployment of enterprise-ready software tailored to client business, eliminating repeat work and embedding long-term strategic advantage.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractCustom enterprise engagement - pricing based on project scope and complexity

Go-to-market motion2 records

Distribution channels2 records

Marketing channels6 records

Visfo product offering

Product offering

Core offering

Visfo is a UK-based life sciences strategic intelligence company that combines consulting engagements with a proprietary SaaS platform to help pharmaceutical, biotech, and consumer health organizations solve complex data challenges. The company delivers high-impact data science consulting projects spanning market access, R&D, medical affairs, and commercial decision support, alongside its HelixAI delivery platform that structures projects from scoping to solution with AI-powered summarization, self-serve analytics, and integrated insight feeds. Engagements typically begin as consulting projects and evolve into longer-term enterprise software relationships built on a comprehensive healthcare data landscape covering clinical, scientific, competitive, and digital domains.

Product overview

VISFO is a life sciences strategic intelligence company that combines SaaS consulting services with a proprietary software platform. Its core product is HelixAI, an AI-enhanced delivery system that structures data science projects from scoping through solution, providing self-serve analytics, AI-powered publication summarization, custom alerts, and integrated insight feeds. Complementing HelixAI are four data landscape modules — Clinical, Scientific, Competitive, and Digital — covering claims data, literature mapping, competitive pipelines, and social/digital signals. These data modules feed into tailored interactive Intelligence Boards and Dashboards developed during consulting engagements. The company pairs consulting engagements with rapid software prototyping, maturing validated solutions into enterprise-grade custom software.

Differentiator

Problem solved

Functional benefit

Products and services

  • HelixAI

Quantifiable outcome

  • Initial delivery in 4 weeks for FDA approval analysis case
  • +2 more outcomes

Companies that use Visfo

Customer profile

Named customers12 records

Segments3 records

Ideal customer profiles3 records

Visfo technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability8 records

Feature5 records

Visfo partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core and secondary.

  • University of YorkcoreStrategic or Co-development Partner · 1 January 2024Partnership includes the Enigma scholarship programme for undergraduate students from widening participation backgrounds. The collaboration also involves research partnerships with PhD students working within Haematology Malignancy Diagnostic Services at St James's University Hospital. Visfo's founder established the scholarship programme to widen participation in the healthcare technology sector.
  • Oncology Access SolutionscoreStrategic or Co-development Partner · 1 January 2023Collaboration to author a publication on critical success factors for developing CAR T-cell therapies for cancer. The partnership focuses on planning the road ahead for CAR-T development and creating a modified approach to developing Target Product Profiles (TPP). Both companies contribute expertise in oncology market access and strategic intelligence.
  • TakedasecondaryOthersTakeda appears as a client logo on Visfo's website, indicating an active client relationship in the pharmaceutical sector.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Visfo competitors and assessment

Company assessment

Direct peers

  • Axtria: Data analytics and AI platform company serving pharma with commercial operations, real-world evidence, and customer engagement solutions - directly comparable to VISFO's data science + software stack for life sciences.
  • Trinity Life Sciences: US-based strategic consulting and analytics firm serving pharma and biotech with commercial strategy, competitive intelligence, and evidence generation - very similar offering to VISFO's consulting-plus-platform model.
  • Eularis: Specialist pharma strategic analytics firm using AI and data science to support commercial strategy, market access, and launch decisions across pharma clients - very close fit to VISFO's consulting model.
  • Evaluate (Norstella): Provides commercial intelligence and forecasting for pharma, including pipeline, pricing, and market access data. Comparable to VISFO's competitive landscape and market access offerings.
  • Health Advances: Healthcare strategy consulting firm supporting pharma, biotech, and medtech with commercial strategy, market access, and opportunity assessments. Comparable consulting services to VISFO's strategic intelligence practice.
  • Definitive Healthcare: Provider of healthcare commercial intelligence, analytics, and SaaS to life sciences companies. Overlaps with VISFO's clinical/competitive intelligence and data landscape products.
  • ZS Associates: Global consulting and technology firm helping pharma companies with sales, marketing, and analytics strategies. Their AI/data capabilities and pharma focus mirror VISFO's strategic intelligence and SaaS delivery model.

Broad incumbents

  • GlobalData Healthcare: Provides pharma market intelligence, clinical trial data, and industry analytics across multiple therapeutic areas. Comparable to VISFO's competitive and scientific landscape offerings.
  • Informa Pharma Intelligence (Citeline): Provides pharma intelligence, clinical trial data, and drug development analytics. Their analytics products and competitive intelligence databases directly compete with VISFO's clinical and competitive data landscape modules.
  • IQVIA: Global leader in life sciences analytics, R&D services, and commercial intelligence. Overlaps with VISFO's pharma intelligence, market access, and consulting offerings, but as part of a much broader portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Visfo social profiles

Digital presence

Visfo financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Visfo leadership team

Management profile

Number of profiles

Profiles10 records

Visfo funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Visfo M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Visfo

What does Visfo do?

Visfo is a UK-based life sciences strategic intelligence company that combines consulting engagements with a proprietary SaaS platform to help pharmaceutical, biotech, and consumer health organizations solve complex data challenges. The company delivers high-impact data science consulting projects spanning market access, R&D, medical affairs, and commercial decision support, alongside its HelixAI delivery platform that structures projects from scoping to solution with AI-powered summarization, self-serve analytics, and integrated insight feeds. Engagements typically begin as consulting projects and evolve into longer-term enterprise software relationships built on a comprehensive healthcare data landscape covering clinical, scientific, competitive, and digital domains.

Is Visfo a public or private company?

Visfo is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Visfo founded?

Visfo was founded in 2018. It employs 11 to 50 people.

Where is Visfo based?

Visfo is headquartered in Brighouse, United Kingdom, in the Europe region.

How does Visfo make money?

Three revenue lines are on record. Strategic Consulting Services are the primary driver. The others are saaS Software Platform (HelixAI) and software Development and Customization.

Who are Visfo's main competitors?

Direct peers on record are Axtria, Trinity Life Sciences, Eularis, Evaluate (Norstella), Health Advances, Definitive Healthcare and ZS Associates. Broad incumbents are GlobalData Healthcare, Informa Pharma Intelligence (Citeline) and IQVIA.

Does Visfo have an API?

No public API is recorded for Visfo.

What industry is Visfo in?

Visfo's product category is Pharmaceutical Intelligence Software. Its primary akta.pro industry code is BPAEAHAD, Business Intelligence, Reporting & Visualization Services, with a secondary code of HLAGALAJ, PV Regulatory Submissions & Safety Reporting (E2B/CIOMS/Expedited). Its NAICS code is 54161 and its SIC code is 8742.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales